We further investigated cumulative effects of variants using a gene-wide approach and identified three candidate genes in different analyses: CABLES1 and PPP2R5C in high-grade serous ovarian cancers without and with adjustment for FIGO stage, respectively, and FAM35A in the overall EOC analysis. This evidence concerns the gene SHLD2 and ovarian serous adenocarcinoma.